Pattern of Dyslipidaemia among Patients with Diabetic Kidney Disease, in Northeastern Nigeria
Asian Journal of Research in Nephrology, Volume 5, Issue 3,
Introduction: Diabetic Diabetes mellitus is a chronic metabolic disorder of carbohydrates, lipids and protein resulting from absolute or relative lack of insulin. The myriad of metabolic derangements lead to development of complications such as DKD. Insulin deficiency is the common pathway in the development of dyslipidemia and chronic hyperglycemia. These two factors appear to combine to cause DKD. Dyslipidemia and its characteristics in T2DM patients have not been studied in northeastern Nigeria. This study describes the prevalence and pattern of dyslipidemia among DKD patients and compared with T2DM patients without kidney disease.
Materials and Methods: The study population consisted of adult T2DM patients recruited consecutively from the diabetes clinic of the University of Maiduguri Teaching Hospital, Maiduguri between the periods January to December 2021. Socio-demographic variables including age, sex, weight, BMI as well aslaboratory parameters were obtained from each study participant. Glomerular filtration wasestimated using the CKD-EPI equation and serum lipids were classified according to the WHO recommendation.
Results: Out of318 study subjects recruited from the Diabetic clinic of University of Maiduguri Teaching Hospital; 194(61%) were females and 124(39%) were males. The mean age of the study population was 49.64±11.40 years and a mean duration of DM of 7.00±6.45 years. Mean HbA1C and Fasting blood glucose of the study population were 9.67±8.39% and 11.06±8.31mmol/L respectively. There were 126(39.6%) study participants who had DKD and the prevalence of hypercholesterolemia among them was 50% (total cholesterol > 5.2mmol/L) compared with 35.4% among study participants without DKD.
Conclusion: The present study showed that lipid abnormalities are common among DKD patients in northeastern Nigeria. Dyslipidemia is a known risk factor for cardiovascular disease and kidney disease progression. Identification and aggressive management of these disorders will help in slowing down the progression chronic kidney disease and prevention of other cardiovascular diseases.
- diabetic kidney disease
- Northeastern Nigeria
How to Cite
American Diabetes Association. Diabetes Care. 2013;36(Suppl 1): S67-S74.
Chiroma I, Sulaiman MM, Mubi BM, Ndahi AA, Mamza AA, Lawan M et al. Prevalence and risk factors of diabetic kidney disease in northeastern Nigeria. Annals of African Medical Research. 2020; 3: 135.
Ghieth O, Farouk N, Nampoory N, Halim MA, Al-Otaibi T. Diabetic kidney disease: world-wide difference of prevalence and risk factors. J Nepropharmacol. 2016;5(1): 49-56.
United States Renal Data System. USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD; 2020.
Azeez TA, Efuntoye O, Abiola BI, Adeyemo SP, Adewale BA. The burden of diabetic kidney disease in Nigeria− systematic review and meta-analysis. Journal of The Egyptian Society of Nephrology and Transplantation. 2021;21(4):194.
Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D et al. Changes in Diabetes-Related Complications in The United States, 1990-2010. N Eng J Med. 2014;3701514-23.
Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab. 2009;5(3):150-9.
Pollaire T, Vessby B, Lithell H. Lipoprotein lipase in skeletal muscle is related to insulin activity. Arterio Thromb. 1991; 11(5):1192-203.
Kimmelstiel P, Wilson C. Intercapillary lesions in the glomeruli of the kidney. Am J Pathol. 1936;12:83-98.
Su W, Cao R, He YC, Guan YF, Ruan XZ. Crosstalk of Hyperglycemia and Dyslipidemia in Diabetic Kidney Disease. Kidney Dis 2017;3:171-180
Choi ME.Mechanism of transforming growth factor-beta1signaling. Kidney Int Suppl. 2000;77: S53-S58.
Sulaiman MM, Chiroma I, Ndahi AA, Lawan M, Loskurima U, Shettima J et al. Gender Disparity in prevalence and risk factors of chronic kidney disease among patients with type 2 diabetes in northeastern Nigeria. Kanem J Med Sci. 2021;15(2):100-105.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentrated cholesterol I plasma, without use of the preparative of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
Jellinger PS, Smiyth DA, Mehta AE, et al. American association of clinical endocrinologist҆ guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocr Pract. 2012;18 Suppl 1:1-78.
James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the eighth joint national committee (JNC8). JAMA. 2014;311:507-20.
World Health Organization. Physical status: the use and Interpretation of Anthropometry; 1995. Accessed 12 November 2016.
World Health Organization. Waist circumference and waist-hip ratio: report of a WHO expert consultation, Geneva, 8-11 December 2008, 2011. Accessed 13 December 2016.
American Diabetes Association. Standard of Medical care in Diabetes. Diabetes Care 2016;39(Supplement 1):51-52.
Jisieike-Onuigbo NN, Unuigbe EI, Kalu OA, Oguejiofor CO, Onuigbo PO. Prevalence of dyslipidemia among adult diabetic patients with overt diabetic nephropathy in Anambra State South- East Nigeria. Niger J Clin Pract. 2011; 14:171-5.
Kajingulu FM, Lepira FB, Mbutiwi FI, Makulo JR, Sumaili BK, Bukabu JB et al. Albuminuria Status and Pattern of Dyslipidemia Among Type 2 Diabetes Black Patients Managed at a Tertiary Health Care Hospital: A Post hoc Analysis. Saudi J Kidney Dis Transpl. 2018;29(3): 649-657.
Sarfaz M, Sajid S, Ashraf MA. Prevalence and pattern of dyslipidemia in hyperglycemic patients and its associated factors among Pakistani population. Saudi J Biol Sci. 2016;23:761-766.
Okaka EI, Eiya BO. Prevalence and pattern of dyslipidemia in a rural community in Southern Nigeria. African Journal of Medical and Health Sciences. 2013;12(2):82.
Yan L, Xu MT, Yuan L, Chen B, Xu ZR, Guo QH et al. Prevalence of dyslipidemia and its control in type 2 diabetes: a multi-centre study in endocrinology clinics of China. J Clin Lipid
Chen HC, Guh JY, Chang JM, Hsieh MC, Shin SJ, Lai YH. Role of lipid control in diabetic kidney disease. Kidney Int (Suppl). 2005;67(94): S60-62.
Chen SC, Hung CC, Kuo MC, Lee JJ, Chiu YW, Chang JM et al. Association of dyslipidemia with renal outcomes in chronic kidney disease. PLOS One. 2013;8(2):e55643.
Abstract View: 132 times
PDF Download: 44 times